SARS-CoV-2 nosocomial infection: Real-world results of environmental surface testing from a large tertiary cancer center.
Mansi R ShahImraan JanJeremy JohnsKuldip SinghPallavi KumarNorma BelarminoKara J SaggiomoCarolyn HayesKimyatta WashingtonDeborah L ToppmeyerBruce G HafftySteven K LibuttiAndrew M EvensPublished in: Cancer (2021)
The potential risks of nosocomial infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have deterred patients with cancer from seeking timely care despite consensus guidelines. This study has found negligible rates of environmental contamination with SARS-CoV-2 across a multitude of commonly used surfaces in outpatient and inpatient hematology/oncology settings with adherence to strict infection control protocols.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- human health
- palliative care
- risk assessment
- coronavirus disease
- mental health
- clinical practice
- squamous cell carcinoma
- drinking water
- type diabetes
- acinetobacter baumannii
- young adults
- pain management
- multidrug resistant
- health risk
- adipose tissue
- glycemic control
- affordable care act
- health insurance